Atopisk Dermatitt
Artikler
Sleep and QOL: the full impact on patients coping with the burden of AD
Understanding the full scope of AD—the unseen burden on patients.
Atopic dermatitis pathophysiology: type 2 inflammation & cytokines
Beneath the skin of patients with AD—type 2 inflammation and the cytokines involved.
Underneath the Skin: Hidden Challenges of Uncontrolled AD and PN
What are the hidden challenges of living with uncontrolled Atopic Dermatitis (AD) and Prurigo Nodularis (PN)?
Advancing Treatment for Uncontrolled AD and PN: New Approaches
As we continue to advance in our understanding and treatment capabilities, our response to uncontrolled AD and PN becomes more effective, paving the way for a future where patients can lead healthier, more comfortable lives8.
Exploring the Unique Characteristics of Atopic Dermatitis (AD) and Prurigo Nodularis (PN)
Explore the distinct clinical manifestations of Atopic Dermatitis (AD) and Prurigo Nodularis (PN), their impact on patients' lives, and the common thread of type 2 inflammation. Understand how these chronic skin conditions differ and intersect in this comprehensive overview.
Long-Term Efficacy and Safety of Dupixent in Moderate-to-Severe Atopic Dermatitis: 5-Year Open-Label Extension Study Results
Atopic dermatitis (AD) is a chronic inflammatory skin condition that can significantly impact patients' quality of life. Dupixent (dupilumab) has emerged as a treatment for moderate-to-severe AD. This article summarizes the findings of a 5-year open-label extension study (Beck et al, 2024), providing insights into the long-term efficacy and safety profile of Dupixent for dermatologists managing patients with persistent AD.
Arrangementer
EADV 2025 with Sanofi: Advanced Dermatology Resources
Discover Sanofi at EADV2025 featuring BioDay registry findings, expert panels, and networking opportunities for dermatology professionals in Paris.
DERM 360°: Research in Reality - RWE in Long Term AD and PN Management
8 may 2025 - Expert panel discussion
DERM 360° Roundtable: Patient Reported Outcome Measures (PROMs) in Clinical Practice
3rd of December 2024
Utdannelse
Managing Pediatric Atopic Dermatitis
A DermTalks Podcast – Atopic Dermatitis in Special Populations. This podcast series is dedicated to exploring the management of atopic dermatitis in specific patient groups.
Speaker : Dr. Hannah de Leye, UZ Brussel, Belgium
Managing Atopic Dermatitis During Pregnancy and Breastfeeding
A DermTalks Podcast – Atopic Dermatitis in Special Populations. This podcast series is dedicated to exploring the management of atopic dermatitis in specific patient groups.
Speaker : Dr. Klas Agerberg, Uppsala University Hospital, Sweden
Managing Atopic Dermatitis in Patients with Comorbidities
A DermTalks Podcast – Atopic Dermatitis in Special Populations. This podcast series is dedicated to exploring the management of atopic dermatitis in specific patient groups.
Speaker : Dr. Jon Anders Halvorsen, Oslo, Norway
Managing Atopic Dermatitis in the Elderly
A DermTalks Podcast – Atopic Dermatitis in Special Populations. This podcast series is dedicated to exploring the management of atopic dermatitis in specific patient groups.
Speaker : Dr. Stine Simonsen, Copenhagen University Hospitals, Denmark
Produkter
